Alexander Vos

Biography

Alexander Vos has 20 years of leadership experience in the pharma and biotech industry. Following his graduate studies of pharmacy and pharmacology in Amsterdam, Netherlands, and at the Mayo Clinic in the United States, he obtained a MBA from Stanford University in the United States (1989). After completing his studies, Alexander Vos spent five years as a strategy consultant working for the international pharmaceutical practice of McKinsey & Co. He subsequently worked at Genzyme Therapeutics Europe, holding several executive positions such as European Marketing Director and Director of Business Development, before assuming global responsibility for the joint venture between Genzyme Corporation and Pharming NV, which pursued the goal of developing an innovative therapy for a genetic muscular disease. From 2000 to 2004, Mr. Vos served as Chief Executive Officer of MediService AG (Switzerland), one of the leading specialty pharmacy service companies in Europe, which was successfully sold to Galenica AG. Before joining PharmaCell, he worked for PAION AG, where he was a Member of the Management Board (“Vorstand”) and Chief Operating Officer. PAION is a clinical stage biopharmaceutical company based in Aachen (Germany) and Cambridge (UK) that is listed on the Frankfurt Stock Exchange.  

Research Interest

 Molecular Biology